High expression of RRM2 promotes the pathogenesis of malignant ovarian endometriosis.
preprint
OA: green
CC0
Abstract
Abstract Objective: Our objective was to investigate the upregulated expression of ribonucleotide reductase M2 (RRM2) in the ectopic endometrium (EC) of ovarian endometriosis (OE) patients that may indicate malignant transformation. RRM2 may be used as a marker of OE, which contribute to the research of the mechanism of the malignant transformation of OE. Methods: The gene expression profiles of ovarian cancer and OE were downloaded from Gene Expression Omnibus (GEO), and a common hub gene, RRM2, was identified. The expression of RRM2 was low in OE and high in ovarian cancer. A total of 44 patients with endometriosis-associated ovarian cancers (EAOC) and 44 with OE were enrolled in this study. Immunohistochemistry (IHC) and real-time quantitative polymerase chain reaction (RT-qPCR) were used to detect the expression of RRM2, while the relationship between RRM2 and Ki-67 was analyzed by IHC co-localization. Results: There was no significant difference in the expression of RRM2 in the eutopic endometrium (EU), EC, and cancer tissues of EAOC patients. Compared with OE patients, the mRNA and protein expression levels of RRM2 were higher in the EC of EAOC patients (p<0.01). Moreover, the high expression of RRM2 was consistent with the expression of Ki-67 in EC of EAOC patients. Conclusions: The upregulated expression of RRM2 in the EC of OE patients may indicate malignant transformation. RRM2 may be used as a marker of OE, which allows the investigation of the mechanism of the malignant transformation of OE.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Endometriosis and ovarian cancer: Thoughts on shared pathophysiology via openalex
- Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses via openalex
- New knowledge and insights about the malignant transformation of endometriosis via openalex
- Ovarian and Extraovarian Endometriosis-Associated Cancer via openalex
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management via openalex
- Ovarian endometrioma—Risks factors of ovarian cancer development via openalex
- Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells In Vitro via openalex
- Prognostic Importance of Hyperplasia and Atypia in Endometriosis via openalex
- W2305551225 via openalex
- W2412507950 via openalex
- W2937151884 via openalex
- W3004614578 via openalex
- W1536062643 via openalex
- W4256321774 via openalex
- W1977179006 via openalex
- W2043977606 via openalex
- W2049775573 via openalex
- W2050507823 via openalex
- W2103041841 via openalex
- W2122761469 via openalex
- W2141689006 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:45:00.660873+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK